Park National Corp Novartis Ag Transaction History

Park National Corp

  • $2.82 Billion
  • Q3 2024

A detailed history of Park National Corp transactions in Novartis Ag stock. As of the latest transaction made, Park National Corp holds 14,946 shares of NVS stock, worth $1.56 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
14,946
Previous 15,350 2.63%
Holding current value
$1.56 Million
Previous $1.63 Million 5.2%
% of portfolio
0.06%
Previous 0.06%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 01, 2024
SELL
$106.13 - $120.89 $42,876 - $48,839
-404 Reduced 2.63%
14,946 $1.72 Million
Q2 2024

Jul 15, 2024
SELL
$92.57 - $107.37 $63,317 - $73,441
-684 Reduced 4.27%
15,350 $1.63 Million
Q1 2024

Apr 01, 2024
SELL
$95.27 - $108.47 $178,917 - $203,706
-1,878 Reduced 10.48%
16,034 $1.55 Million
Q4 2023

Jan 02, 2024
SELL
$92.27 - $101.54 $45,858 - $50,465
-497 Reduced 2.7%
17,912 $1.81 Million
Q3 2023

Oct 02, 2023
SELL
$94.73 - $105.13 $41,870 - $46,467
-442 Reduced 2.34%
18,409 $1.88 Million
Q2 2023

Jul 03, 2023
SELL
$92.52 - $104.91 $62,821 - $71,233
-679 Reduced 3.48%
18,851 $1.9 Million
Q1 2023

Apr 03, 2023
SELL
$80.03 - $92.81 $94,675 - $109,794
-1,183 Reduced 5.71%
19,530 $1.8 Million
Q4 2022

Feb 06, 2023
SELL
$75.55 - $92.52 $149,437 - $183,004
-1,978 Reduced 8.72%
20,713 $1.88 Million
Q3 2022

Oct 03, 2022
SELL
$74.61 - $87.26 $67,895 - $79,406
-910 Reduced 3.86%
22,691 $1.72 Million
Q2 2022

Jul 01, 2022
SELL
$80.52 - $93.75 $304,687 - $354,750
-3,784 Reduced 13.82%
23,601 $2 Million
Q1 2022

Apr 01, 2022
SELL
$80.11 - $90.62 $336,622 - $380,785
-4,202 Reduced 13.3%
27,385 $2.4 Million
Q4 2021

Jan 04, 2022
SELL
$79.7 - $88.13 $866,498 - $958,149
-10,872 Reduced 25.61%
31,587 $2.76 Million
Q3 2021

Oct 01, 2021
SELL
$81.78 - $95.14 $147,694 - $171,822
-1,806 Reduced 4.08%
42,459 $3.47 Million
Q2 2021

Jul 01, 2021
SELL
$85.24 - $94.15 $1.2 Million - $1.33 Million
-14,076 Reduced 24.13%
44,265 $4.04 Million
Q1 2021

Apr 01, 2021
SELL
$83.5 - $98.47 $1.71 Million - $2.02 Million
-20,524 Reduced 26.02%
58,341 $4.99 Million
Q4 2020

Jan 04, 2021
SELL
$78.07 - $94.43 $281,208 - $340,136
-3,602 Reduced 4.37%
78,865 $7.45 Million
Q3 2020

Oct 01, 2020
SELL
$82.14 - $91.0 $1.54 Million - $1.71 Million
-18,799 Reduced 18.56%
82,467 $7.17 Million
Q2 2020

Jul 01, 2020
SELL
$80.93 - $91.1 $1.9 Million - $2.13 Million
-23,422 Reduced 18.78%
101,266 $8.84 Million
Q1 2020

Apr 01, 2020
SELL
$70.67 - $99.01 $610,659 - $855,545
-8,641 Reduced 6.48%
124,688 $10.3 Million
Q4 2019

Jan 02, 2020
SELL
$84.35 - $95.37 $177,135 - $200,277
-2,100 Reduced 1.55%
133,329 $12.6 Million
Q3 2019

Oct 01, 2019
SELL
$85.54 - $94.26 $662,250 - $729,760
-7,742 Reduced 5.41%
135,429 $11.8 Million
Q2 2019

Jul 01, 2019
SELL
$75.4 - $92.8 $3.52 Million - $4.33 Million
-46,661 Reduced 24.58%
143,171 $13.1 Million
Q1 2019

Apr 01, 2019
SELL
$75.32 - $86.15 $2.69 Million - $3.08 Million
-35,754 Reduced 15.85%
189,832 $18.3 Million
Q4 2018

Jan 02, 2019
SELL
$73.66 - $82.02 $3.45 Million - $3.84 Million
-46,864 Reduced 17.2%
225,586 $19.4 Million
Q3 2018

Oct 02, 2018
SELL
$66.94 - $77.43 $2.16 Million - $2.5 Million
-32,302 Reduced 10.6%
272,450 $23.5 Million
Q2 2018

Jul 02, 2018
BUY
$64.91 - $73.36 $399,196 - $451,164
6,150 Added 2.06%
304,752 $23 Million
Q1 2018

Apr 02, 2018
SELL
$70.39 - $84.15 $181,817 - $217,359
-2,583 Reduced 0.86%
298,602 $24.1 Million
Q4 2017

Jan 02, 2018
SELL
$72.33 - $77.64 $274,564 - $294,721
-3,796 Reduced 1.24%
301,185 $25.3 Million
Q3 2017

Oct 02, 2017
BUY
$74.14 - $77.27 $22.6 Million - $23.6 Million
304,981
304,981 $26.2 Million

Others Institutions Holding NVS

# of Institutions
1,435
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Park National Corp Portfolio

Follow Park National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park National Corp , based on Form 13F filings with the SEC.

News

Stay updated on Park National Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email